SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-21-119370
Filing Date
2021-04-16
Accepted
2021-04-16 16:11:51
Documents
1
Effectiveness Date
2021-04-16

Document Format Files

Seq Description Document Type Size
1 S-8 POS d135008ds8pos.htm S-8 POS 27104
  Complete submission text file 0001193125-21-119370.txt   28222
Mailing Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS, INC. (Filer) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-191700 | Film No.: 21831624
SIC: 2834 Pharmaceutical Preparations